SG Americas Securities’s Enzymotec Ltd ENZY Stock Holding History

SG Americas Securities’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,800	Closed	-$116K	–	3756
2017 Q4	$116K	Buy	+9,800	New	+$114K	﹤0.01%	2782

SG Americas Securities's ENZY Position: Q1 2018 in Review

SG Americas Securities sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 9,800 shares — an estimated $116K sold.

SG Americas Securities first reported a position in ENZY in Q4 2017 and held it in 1 quarter. The position peaked at $116K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

SG Americas Securities reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
SG Americas Securities sold 9,800 Enzymotec Ltd shares in Q1 2018, an estimated $116K.
SG Americas Securities first reported a position in Enzymotec Ltd in Q4 2017 and held it in 1 quarter.
SG Americas Securities's Enzymotec Ltd position peaked at $116K in Q4 2017.
0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.